APRIL RIVERA: Open Payments
NPI 1821359183 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 40 payments from 19 companies in 2025. Trend: 2023 $111 · 2024 $964 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $355 |
| Lundbeck LLC | 3 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| LivaNova USA, Inc. | 1 | $47 |
| UCB, Inc. | 1 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $22 |
| JAZZ PHARMACEUTICALS INC. | 1 | $21 |
Products named: QULIPTA, VYEPTI, INGREZZA, UBRELVY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Nayzilam, ULTOMIRIS, Leqembi.
Industry payments across NM — which companies pay providers there.
